Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
149,544,182
-
Number of holders
-
104
-
Total 13F shares, excl. options
-
45,418,262
-
Shares change
-
+216,512
-
Total reported value, excl. options
-
$1,079,557,657
-
Value change
-
+$3,680,968
-
Number of buys
-
47
-
Number of sells
-
-42
-
Price
-
$23.77
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q4 2021
121 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q4 2021.
Avidity Biosciences, Inc. - Common Stock (RNA) has 104 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 45,418,262 shares
of 149,544,182 outstanding shares and own 30.37% of the company stock.
Largest 10 shareholders include PRICE T ROWE ASSOCIATES INC /MD/ (7,731,846 shares), RTW INVESTMENTS, LP (4,795,000 shares), FMR LLC (3,776,524 shares), BlackRock Inc. (3,297,480 shares), EcoR1 Capital, LLC (2,759,505 shares), FEDERATED HERMES, INC. (2,474,500 shares), Cormorant Asset Management, LP (2,012,115 shares), VANGUARD GROUP INC (2,003,572 shares), Avidity Partners Management LP (1,815,000 shares), and STATE STREET CORP (1,397,403 shares).
This table shows the top 104 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.